» Articles » PMID: 26903998

Transcriptional Regulation of Carbohydrate Utilization Pathways in the Bifidobacterium Genus

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2016 Feb 24
PMID 26903998
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Bifidobacteria, which represent common commensals of mammalian gut, are believed to have positive effects on human health. The influence of certain non-digestible carbohydrates (and their use as so-called prebiotics) on growth and metabolic activity of bifidobacteria is of increasing interest; however, mechanisms of transcriptional control of carbohydrate metabolism are poorly understood in these species. We used a comparative genomics approach to reconstruct carbohydrate utilization pathways and transcriptional regulons in 10 Bifidobacterium genomes. Analysis of regulatory gene regions revealed candidate DNA motifs and reconstructed regulons for 268 transcription factors from the LacI, ROK, DeoR, AraC, GntR, and TetR families that form 64 orthologous groups of regulators. Most of the reconstructed regulons are local and control specific catabolic pathways for host- and diet-derived glycans and monosaccharides. Mosaic distributions of many of these local regulators across Bifidobacterium species correlate with distribution of corresponding catabolic pathways. In contrast, the maltose, galactose, sucrose, and fructose regulons, as well as a novel global LacI-family regulator that is predicted to control the central carbohydrate metabolism and arabinose catabolism genes, are universally present in all 10 studied bifidobacteria. A novel group of TetR-family regulators presumably controls the glucoside and galactoside utilization pathways. Paralogs of the ribose repressor RbsR control the pyrimidine nucleoside utilization genes. Multiple paralogs of the maltose regulator MalR co-regulate large sets of genes involved in maltodextrin utilization. The inferred metabolic regulons provide new insights on diverse carbohydrate utilization networks in bifidobacteria that can be employed in metabolic modeling, phenotype prediction and the rational development of novel prebiotics.

Citing Articles

Beneficial Effects of Reconstructed Human Gut Microbiota by Ginseng Extract Fermentation on Intestinal Cell Lines.

Finazzi M, Bovio F, Forcella M, Lasagni M, Fusi P, Di Gennaro P Microorganisms. 2025; 13(1).

PMID: 39858960 PMC: 11768043. DOI: 10.3390/microorganisms13010192.


Unveiling the neonatal gut microbiota: exploring the influence of delivery mode on early microbial colonization and intervention strategies.

Ma G, Chen Z, Li Z, Xiao X Arch Gynecol Obstet. 2024; 310(6):2853-2861.

PMID: 39589476 DOI: 10.1007/s00404-024-07843-1.


Integrative genomic reconstruction of carbohydrate utilization networks in bifidobacteria: global trends, local variability, and dietary adaptation.

Arzamasov A, Rodionov D, Hibberd M, Guruge J, Kazanov M, Leyn S bioRxiv. 2024; .

PMID: 39005317 PMC: 11245093. DOI: 10.1101/2024.07.06.602360.


A Narrative Review of Intestinal Microbiota's Impact on Migraine with Psychopathologies.

Francavilla M, Facchetti S, Demartini C, Zanaboni A, Amoroso C, Bottiroli S Int J Mol Sci. 2024; 25(12).

PMID: 38928361 PMC: 11203823. DOI: 10.3390/ijms25126655.


Genomic and ecological approaches to identify the prototype of the healthy human gut microbiota.

Argentini C, Lugli G, Tarracchini C, Fontana F, Mancabelli L, Viappiani A Front Microbiol. 2024; 15:1349391.

PMID: 38426063 PMC: 10902438. DOI: 10.3389/fmicb.2024.1349391.


References
1.
Lugli G, Milani C, Turroni F, Duranti S, Ferrario C, Viappiani A . Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics. Appl Environ Microbiol. 2014; 80(20):6383-94. PMC: 4178631. DOI: 10.1128/AEM.02004-14. View

2.
OConnell K, OConnell Motherway M, Liedtke A, Fitzgerald G, Ross R, Stanton C . Transcription of two adjacent carbohydrate utilization gene clusters in Bifidobacterium breve UCC2003 is controlled by LacI- and repressor open reading frame kinase (ROK)-type regulators. Appl Environ Microbiol. 2014; 80(12):3604-14. PMC: 4054134. DOI: 10.1128/AEM.00130-14. View

3.
Vaughan E, Heilig H, Ben-Amor K, de Vos W . Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev. 2005; 29(3):477-90. DOI: 10.1016/j.femsre.2005.04.009. View

4.
Leyn S, Kazanov M, Sernova N, Ermakova E, Novichkov P, Rodionov D . Genomic reconstruction of the transcriptional regulatory network in Bacillus subtilis. J Bacteriol. 2013; 195(11):2463-73. PMC: 3676070. DOI: 10.1128/JB.00140-13. View

5.
Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B . Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11(8):506-14. DOI: 10.1038/nrgastro.2014.66. View